美股A股
StockGist
Back
8-K2026-04-23· qwen-plus

NUTX · Nutex Health, Inc.

0001628280-26-026828

SEC filing

Summary

At its April 23, 2026 annual meeting, Nutex Health, Inc. elected seven director nominees, approved named executive officer compensation on an advisory basis, and ratified Grant Thornton LLP as its independent auditor for 2026.

Key takeaways

Full analysis

The April 23, 2026 annual meeting reflects routine corporate governance outcomes with no contested elections or adverse voting results. All director nominees were elected, though vote withhold rates varied—ranging from 0.7% for Frank E. Jaumot to 4.9% for Warren Hosseinion—suggesting differential levels of shareholder confidence across the board. The advisory say-on-pay vote passed with strong support (94.7% of votes cast), consistent with typical outcomes for mid-cap healthcare services firms absent recent performance or governance controversies. Notably, broker non-votes were uniformly high (1,256,968 shares) for director elections and the compensation proposal, reflecting the absence of discretionary voting authority for brokers on these matters under NYSE rules; however, no broker non-votes were recorded for the auditor ratification, which is a routine procedural matter typically eligible for discretionary voting. The total shares voted (3,900,175) represented 69.29% of eligible shares, indicating moderate participation. No changes to board composition, executive leadership, or audit oversight occurred beyond standard annual re-election and ratification.